Lista de obras - Gilles Darcis - Dominio Público Uruguay

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression ⬇️

artículo científico publicado en 2015

Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence

artículo científico publicado en 2019

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs

artículo científico publicado en 2019

Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway

article

Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy

artículo científico publicado en 2020

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

artículo científico publicado en 2020

Epigenetic control of HIV-1 post integration latency: implications for therapy

artículo científico publicado en 2015

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV

scientific article published on 18 October 2020

Exploring the anatomical HIV reservoirs: role of the testicular tissue

artículo científico publicado en 2016

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium.

artículo científico publicado en 2017

Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017.

artículo científico publicado en 2018

HIV Latency: Should We Shock or Lock?

artículo científico publicado en 2017

HIV cure : a realistic perspective ?

artículo científico publicado en 2017

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments

scientific article published on 01 April 2019

Human Immunodeficiency Virus Resistance to Dolutegravir: Are We Looking in the Wrong Place?

scientific article published on 01 November 2018

Impact of coronavirus pandemic and containment measures on HIV diagnosis

scientific article published on 24 August 2020

Louse-borne relapsing fever in a refugee from Somalia arriving in Belgium

artículo científico publicado en 2016

Molecular Control of HIV and SIV Latency

artículo científico publicado en 2017

Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study

artículo científico

Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC

artículo científico publicado en 2020

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir

artículo científico publicado en 2016

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy

artículo científico publicado en 2017

Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

artículo científico publicado en 2015

Shocking HIV-1 with immunomodulatory latency reversing agents

artículo científico publicado en 2021

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.

artículo científico publicado en 2018

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape

article

The Molecular Biology of HIV Latency

article

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

artículo científico publicado en 2019

The effect of treatment simplification on HIV reservoirs.

artículo científico publicado en 2017

Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?

scientific article published on 01 April 2019

Update in HIV therapy: tenofovir alafenamide

artículo científico publicado en 2016

Wild-type HIV infection despite PrEP: a lot to learn from a case report.

artículo científico publicado en 2018

[Application of the Upper Council of Health recommendations in the respiratory isolation of patients with pulmonary tuberculosis at Liège University Hospital.]

artículo científico publicado en 2019

[Emergency department utilization by HIV-positive adults in a Belgian setting]

scientific article published on 01 January 2019

Lista de obras de Gilles Darcis

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression ⬇️

Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs

Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway

Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Epigenetic control of HIV-1 post integration latency: implications for therapy

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV

Exploring the anatomical HIV reservoirs: role of the testicular tissue

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium.

Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017.

HIV Latency: Should We Shock or Lock?

HIV cure : a realistic perspective ?

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments

Human Immunodeficiency Virus Resistance to Dolutegravir: Are We Looking in the Wrong Place?

Impact of coronavirus pandemic and containment measures on HIV diagnosis

Louse-borne relapsing fever in a refugee from Somalia arriving in Belgium

Molecular Control of HIV and SIV Latency

Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study

Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy

Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

Shocking HIV-1 with immunomodulatory latency reversing agents

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape

The Molecular Biology of HIV Latency

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

The effect of treatment simplification on HIV reservoirs.

Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?

Update in HIV therapy: tenofovir alafenamide

Wild-type HIV infection despite PrEP: a lot to learn from a case report.

[Application of the Upper Council of Health recommendations in the respiratory isolation of patients with pulmonary tuberculosis at Liège University Hospital.]

[Emergency department utilization by HIV-positive adults in a Belgian setting]